CERE
Cerevel Therapeutics Holdings, Inc.
Chief Medical Officer Ramiro Sanchez sold $414K of Cerevel Therapeutics Holdings, Inc.
Sold$413,700
$41.37Price
10,000Shares
−100%Stake
What CERE did after the filing
- The stock from Mon, Dec 11 close, $41.05
- +2.6%
- S&P 500, same days
- +6.1%
Measured over 30 trading days, to the Jan 25 close.
Traded Thu, Dec 7. Filed Mon, Dec 11, 11:17 AM ET, during the session. Returns use the Dec 11 close and the Jan 25 close. Not investment advice.